Evidence map›Paper›PMID 38274296›Full record

ArticleACG case reports journal2024

Recurrence of Drug-Induced Lupus Secondary to Vedolizumab Use in a Patient With Crohn's Disease.

Vanessa I Rodriguez, Akshay Mathavan, Akash Mathavan, Diana N Rodriguez, Catalina Sanchez Alvarez, Angela Pham

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ACG case reports journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vanessa I RodriguezDepartment of Internal Medicine, University of South Florida, Tampa, FL.ORCID https://orcid.org/0000-0001-9464-1471
Akshay MathavanDepartment of Internal Medicine, University of Florida, Gainesville, FL.
Akash MathavanDepartment of Internal Medicine, University of Florida, Gainesville, FL.
Diana N RodriguezDepartment of Internal Medicine, University of Florida, Gainesville, FL.
Catalina Sanchez AlvarezDivision of Rheumatology and Immunology, University of Florida, Gainesville, FL.
Angela PhamDivision of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced lupus is an autoimmune phenomenon characterized by the development of systemic lupus erythematosus-like clinical features after drug exposure. The entity is a clinical diagnosis. Evaluation consists of recognizing systemic lupus erythematosus-like features, identifying an appropriate causative agent, observing elevations of characteristic autoantibodies, and obtaining positive response with drug discontinuation. Vedolizumab is an anti-α

Indexed as

Crohn's diseasedrug-induced lupusIBDinfliximabvedolizumab

Identifiers

PMID38274296
PMCPMC10810571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.